KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting February 25, 2019
Calithera Biosciences Initiates Phase 1 Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis February 21, 2019
Bicycle Therapeutics Announces Publication of Its Paper Demonstrating Utility of Bicycles™ as Imaging Agents February 14, 2019
